Michael is a medical device executive, serial entrepreneur, inventor, and part-time venture capitalist. With a passion for commercializing disruptive technologies for the benefit of patients, he has co-founded 5 companies and achieved 4 successful exits to date. In 2021, Michael sold Devoro Medical to Boston Scientific. He holds BSME and MSME degrees from the University of Delaware and UC Davis, and is the inventor or co-inventor of over 300 patents.
Before founding medical device companies, Michael held senior roles in Technical and Operational leadership at large medical device companies and startups in Silicon Valley. He spent 10 years at Target Therapeutics/Boston Scientific developing endovascular brain aneurysm solutions. He then worked for 12 years at 3 successful medical device startups in executive R&D and Operational roles: BARRX Medical, Baxano Inc, and Silk Road Medical.
Michael’s first two companies, TW Medical and 880 Medical, were sold to Stryker’s Neuro Vascular division in 2015 and 2017 respectively. He also co-founded CardioProlific, which sold to Philips Medical in 2018. Currently, Michael runs his incubator 880 Medical, co-founded Early Bird Medical, serves as a part-time Venture Partner at ShangBay Medical, and is a board member or advisor for select startups.